Psyence Biomedical (PBM) Competitors $4.42 -0.21 (-4.54%) Closing price 04:00 PM EasternExtended Trading$4.43 +0.01 (+0.23%) As of 04:28 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PBM vs. BGXX, INAB, CSCI, HOTH, BLRX, LSB, PHXM, TLPH, CYCN, and ATHAShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include Bright Green (BGXX), IN8bio (INAB), COSCIENS Biopharma (CSCI), Hoth Therapeutics (HOTH), BioLineRx (BLRX), Lakeshore Biopharma (LSB), PHAXIAM Therapeutics (PHXM), Talphera (TLPH), Cyclerion Therapeutics (CYCN), and Athira Pharma (ATHA). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. Bright Green IN8bio COSCIENS Biopharma Hoth Therapeutics BioLineRx Lakeshore Biopharma PHAXIAM Therapeutics Talphera Cyclerion Therapeutics Athira Pharma Psyence Biomedical (NASDAQ:PBM) and Bright Green (NASDAQ:BGXX) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, community ranking, profitability and dividends. Does the media refer more to PBM or BGXX? In the previous week, Psyence Biomedical had 3 more articles in the media than Bright Green. MarketBeat recorded 4 mentions for Psyence Biomedical and 1 mentions for Bright Green. Bright Green's average media sentiment score of 0.95 beat Psyence Biomedical's score of 0.00 indicating that Bright Green is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Psyence Biomedical 0 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Bright Green 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Is PBM or BGXX more profitable? Psyence Biomedical's return on equity of 0.00% beat Bright Green's return on equity.Company Net Margins Return on Equity Return on Assets Psyence BiomedicalN/A N/A N/A Bright Green N/A -88.37%-55.30% Which has stronger valuation and earnings, PBM or BGXX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPsyence BiomedicalN/AN/A-$51.16MN/AN/ABright GreenN/AN/A-$13.13M-$0.06N/A Does the MarketBeat Community believe in PBM or BGXX? Psyence Biomedical and Bright Green both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPsyence BiomedicalN/AN/ABright GreenN/AN/A Which has more volatility and risk, PBM or BGXX? Psyence Biomedical has a beta of -0.11, suggesting that its stock price is 111% less volatile than the S&P 500. Comparatively, Bright Green has a beta of -0.26, suggesting that its stock price is 126% less volatile than the S&P 500. Do institutionals and insiders hold more shares of PBM or BGXX? 77.4% of Psyence Biomedical shares are held by institutional investors. Comparatively, 7.8% of Bright Green shares are held by institutional investors. 3.6% of Psyence Biomedical shares are held by insiders. Comparatively, 62.5% of Bright Green shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. SummaryPsyence Biomedical beats Bright Green on 5 of the 8 factors compared between the two stocks. Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBM vs. The Competition Export to ExcelMetricPsyence BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.52M$6.50B$5.34B$8.42BDividend YieldN/A2.64%5.21%4.11%P/E RatioN/A9.1526.8519.72Price / SalesN/A252.36387.23121.26Price / CashN/A65.8538.2534.62Price / Book-0.076.456.774.51Net Income-$51.16M$144.21M$3.23B$248.32M7 Day PerformanceN/A2.38%1.81%0.60%1 Month Performance26.33%4.50%10.93%13.18%1 Year Performance-99.14%-2.75%17.15%7.39% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMPsyence BiomedicalN/A$4.42-4.5%N/A-99.1%$2.52MN/A0.00N/ANews CoverageBGXXBright GreenN/AN/AN/AN/A$11.47MN/A-1.002News CoverageGap DownINABIN8bio3.2095 of 5 stars$0.13+4.0%$6.00+4,515.4%-87.5%$11.35MN/A-0.1720Gap UpCSCICOSCIENS BiopharmaN/A$3.60-0.1%N/AN/A$11.31M$9.59M-0.3020Gap DownHOTHHoth Therapeutics3.2958 of 5 stars$0.85-0.5%$4.00+372.9%-29.5%$11.17MN/A-0.644Analyst DowngradeBLRXBioLineRx1.6556 of 5 stars$3.64+11.3%$26.00+614.3%-85.4%$10.88M$28.94M-0.4140Upcoming EarningsLSBLakeshore Biopharma0.7068 of 5 stars$1.15+1.8%N/AN/A$10.70M$672.27M0.00773PHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049TLPHTalphera2.8182 of 5 stars$0.52+1.1%$5.00+869.7%-51.8%$10.57M$281,000.00-0.7519Gap DownCYCNCyclerion Therapeutics0.8264 of 5 stars$3.28+5.5%N/A+18.1%$10.53M$2.08M-2.8330Gap UpATHAAthira Pharma1.7032 of 5 stars$0.27-1.4%$13.83+5,059.8%-89.4%$10.47MN/A-0.0940 Related Companies and Tools Related Companies Bright Green Alternatives IN8bio Alternatives COSCIENS Biopharma Alternatives Hoth Therapeutics Alternatives BioLineRx Alternatives Lakeshore Biopharma Alternatives PHAXIAM Therapeutics Alternatives Talphera Alternatives Cyclerion Therapeutics Alternatives Athira Pharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PBM) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe DOJ Just Said Your Money Isn’t YoursWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
